UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Current opinion in immunology, ISSN 0952-7915, 06/2018, Volume 52, pp. 32 - 38
Life Sciences & Biomedicine | Immunology | Science & Technology | Bone Regeneration - genetics | Humans | Stress, Mechanical | Adenosine Triphosphate - biosynthesis | Osteoclasts - metabolism | Receptors, Purinergic P2X7 - genetics | Mechanotransduction, Cellular | Animals | Energy Metabolism | Bone and Bones - metabolism | Receptors, Purinergic P2X7 - metabolism | Osteoblasts - metabolism | Bone Remodeling | Medicine, Experimental | Medical research | Hyperglycemia | Glucose | Dextrose | Index Medicus
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 07/2017, Volume 47, Issue 1, pp. 15 - 31
Life Sciences & Biomedicine | Immunology | Science & Technology | Inflammasomes - metabolism | Infection - drug therapy | Infection - immunology | Humans | Inflammation - immunology | Animals | Purinergic P2X Receptor Agonists - therapeutic use | Inflammation - drug therapy | Receptors, Purinergic P2X7 - metabolism | T-Lymphocytes - immunology | Cell Differentiation | Receptors, Purinergic P2X7 - immunology | Macrophages - immunology | Adenosine | Cell death | Genetic engineering | Cellular signal transduction | Inflammation | Single nucleotide polymorphisms | T cells | Muscle proteins | Health aspects | Adenosine triphosphate | Haplotypes | Alternative splicing | Infections | Single-nucleotide polymorphism | Immunity | Proteins | Signal transduction | Receptors | Cell activation | Lymphocytes | Transcription activation | Purine P2 receptors | Immune system | Cell survival | Neutrophils | Adaptive immunity | Metabolism | Ligands | Transduction | Differentiation | ATP | Cancer | Index Medicus
Journal Article
CNS & neurological disorders drug targets, ISSN 1871-5273, 2012, Volume 11, Issue 6, pp. 705 - 721
Pain | Neurodegeneration | Nervous system | Neuroinflammation | Antagonists | P2X7 receptor | Knock-out | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Ion Channels | Humans | Neuralgia - metabolism | Epilepsy - metabolism | Purinergic P2X Receptor Antagonists - pharmacology | Neurodegenerative Diseases - metabolism | Permeability | Receptors, Purinergic P2X7 - genetics | Receptors, Purinergic P2X7 - physiology | Animals | Receptors, Purinergic P2X7 - metabolism | Mice | Neuroblastoma - metabolism | Channel pores | Animal models | Immune response | Cytokines | Mental disorders | Central nervous system | Cytotoxicity | Inflammation | Pharmacology | Macrophages | Calcium influx | Purine P2X receptors | Neurological diseases | Neurotransmitters | Cell death | Receptor mechanisms | ATP | Communication
Journal Article
Pharmacological reviews, ISSN 0031-6997, 2014, Volume 66, Issue 3, pp. 638 - 675
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Receptors, Purinergic P2X7 - drug effects | Humans | Purinergic P2X Receptor Antagonists - pharmacology | Clinical Trials as Topic | Molecular Targeted Therapy | Receptors, Purinergic P2X7 - genetics | Polymorphism, Genetic | Gene Expression Regulation - drug effects | Animals | Signal Transduction - drug effects | Drug Design | Receptors, Purinergic P2X7 - metabolism | Disease Models, Animal | Index Medicus
Journal Article
Biochemical pharmacology, ISSN 0006-2952, 05/2018, Volume 151, pp. 234 - 244
Pathogens | Inflammation | Immune response | P2X7 | ATP | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Neoplasms - metabolism | Inflammasomes - metabolism | Purinergic P2X Receptor Agonists - administration & dosage | Humans | Neurodegenerative Diseases - drug therapy | Neurodegenerative Diseases - immunology | Purinergic P2X Receptor Antagonists - adverse effects | Inflammation - metabolism | Communicable Diseases - drug therapy | Purinergic P2X Receptor Agonists - therapeutic use | Inflammation - drug therapy | Drug Evaluation, Preclinical | Autoimmune Diseases - metabolism | Purinergic P2X Receptor Antagonists - therapeutic use | Autoimmune Diseases - drug therapy | Autoimmune Diseases - immunology | Purinergic P2X Receptor Agonists - adverse effects | Purinergic P2X Receptor Antagonists - administration & dosage | Clinical Trials as Topic | Inflammation - immunology | Neurodegenerative Diseases - metabolism | Communicable Diseases - metabolism | Neoplasms - drug therapy | Animals | Neoplasms - immunology | Communicable Diseases - immunology | Receptors, Purinergic P2X7 - metabolism | Chronic Disease | Virus diseases | Parasitic diseases | Chronic diseases | B cells | Health aspects | Vascular endothelial growth factor | Index Medicus
Journal Article